203 related articles for article (PubMed ID: 23377855)
1. Bauhinia forficata prevents vacuous chewing movements induced by haloperidol in rats and has antioxidant potential in vitro.
Peroza LR; Busanello A; Leal CQ; Röpke J; Boligon AA; Meinerz D; Libardoni M; Athayde ML; Fachinetto R
Neurochem Res; 2013 Apr; 38(4):789-96. PubMed ID: 23377855
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
Naidu PS; Singh A; Kulkarni SK
Br J Pharmacol; 2002 May; 136(2):193-200. PubMed ID: 12010767
[TBL] [Abstract][Full Text] [Related]
3. Alcohol extract of Bauhinia forficata link reduces lipid peroxidation in the testis and epididymis of adult Wistar rats.
Sampaio CF; Lucchetta NR; Punhagui APF; Banedetti PR; Arakawa NS; Seiva FRF; Fernandes GSA
Microsc Res Tech; 2019 Apr; 82(4):345-351. PubMed ID: 30575198
[TBL] [Abstract][Full Text] [Related]
4. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
5. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
[TBL] [Abstract][Full Text] [Related]
6. Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism.
Kamyar M; Razavi BM; Hasani FV; Mehri S; Foroutanfar A; Hosseinzadeh H
Iran J Basic Med Sci; 2016 Oct; 19(10):1070-1079. PubMed ID: 27872703
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
[TBL] [Abstract][Full Text] [Related]
8. Harpagophytum Procumbens Ethyl Acetate Fraction Reduces Fluphenazine-Induced Vacuous Chewing Movements and Oxidative Stress in Rat Brain.
Schaffer LF; de Freitas CM; Chiapinotto Ceretta AP; Peroza LR; de Moraes Reis E; Krum BN; Busanello A; Boligon AA; Sudati JH; Fachinetto R; Wagner C
Neurochem Res; 2016 May; 41(5):1170-84. PubMed ID: 26732278
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.
Bishnoi M; Chopra K; Kulkarni SK
Psychopharmacology (Berl); 2008 Feb; 196(2):243-54. PubMed ID: 17955214
[TBL] [Abstract][Full Text] [Related]
10. Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats.
Colpo G; Trevisol F; Teixeira AM; Fachinetto R; Pereira RP; Athayde ML; Rocha JB; Burger ME
Neurotox Res; 2007 Oct; 12(3):171-80. PubMed ID: 17967741
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation.
Datta S; Jamwal S; Deshmukh R; Kumar P
Eur J Pharmacol; 2016 Jan; 771():229-35. PubMed ID: 26712377
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.
Busanello A; Leal CQ; Peroza LR; Röpke J; de Moraes Reis E; de Freitas CM; Libardoni M; de Vargas Barbosa NB; Fachinetto R
Neurochem Res; 2017 Nov; 42(11):3033-3040. PubMed ID: 28744755
[TBL] [Abstract][Full Text] [Related]
13. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Avila DS; Burger ME; Calixto JB; Rocha JB; Ferreira J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1478-86. PubMed ID: 17669571
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
[TBL] [Abstract][Full Text] [Related]
15. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.
Shi J; Tan YL; Wang ZR; An HM; Li J; Wang YC; Lv MH; Yan SX; Wu JQ; Soares JC; Yang FD; Zhang XY
Pharmacol Biochem Behav; 2016 Sep; 148():53-8. PubMed ID: 27264436
[TBL] [Abstract][Full Text] [Related]
17. Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia.
Singh A; Naidu PS; Kulkarni SK
Eur J Pharmacol; 2003 Sep; 477(2):87-94. PubMed ID: 14519411
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.
Sonego AB; Prado DS; Vale GT; Sepulveda-Diaz JE; Cunha TM; Tirapelli CR; Del Bel EA; Raisman-Vozari R; Guimarães FS
Brain Behav Immun; 2018 Nov; 74():241-251. PubMed ID: 30217539
[TBL] [Abstract][Full Text] [Related]
19. Effect of Bauhinia forficata extract in diabetic pregnant rats: maternal repercussions.
Damasceno DC; Volpato GT; Calderon Ide M; Aguilar R; Rudge MV
Phytomedicine; 2004 Feb; 11(2-3):196-201. PubMed ID: 15070172
[TBL] [Abstract][Full Text] [Related]
20. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Naidu PS; Kulkarni SK
Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
